From Vial to Drug Delivery Device: Key factors in Transitioning to Combination Products

Combination products are undergoing tremendous growth, driven by the rise in chronic disease indications, demand for self-administered therapies, minimally invasive procedures, and technology advancements. However when transitioning from a vial system to a needle-based combination product, there are many challenges in areas of government regulations, supply chain complexity, and patient outcomes. This webinar addresses these challenges, proper life cycle management, and the transition to a combination product.